Publication Date:
2013-11-26
Description:
An increasing body of evidence points to mitochondrial dysfunction as a contributor to the molecular pathogenesis of neurodegenerative diseases such as Parkinson's disease. Recent studies of the Parkinson's disease associated genes PINK1 (ref. 2) and parkin (PARK2, ref. 3) indicate that they may act in a quality control pathway preventing the accumulation of dysfunctional mitochondria. Here we elucidate regulators that have an impact on parkin translocation to damaged mitochondria with genome-wide small interfering RNA (siRNA) screens coupled to high-content microscopy. Screening yielded gene candidates involved in diverse cellular processes that were subsequently validated in low-throughput assays. This led to characterization of TOMM7 as essential for stabilizing PINK1 on the outer mitochondrial membrane following mitochondrial damage. We also discovered that HSPA1L (HSP70 family member) and BAG4 have mutually opposing roles in the regulation of parkin translocation. The screens revealed that SIAH3, found to localize to mitochondria, inhibits PINK1 accumulation after mitochondrial insult, reducing parkin translocation. Overall, our screens provide a rich resource to understand mitochondrial quality control.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Hasson, Samuel A -- Kane, Lesley A -- Yamano, Koji -- Huang, Chiu-Hui -- Sliter, Danielle A -- Buehler, Eugen -- Wang, Chunxin -- Heman-Ackah, Sabrina M -- Hessa, Tara -- Guha, Rajarshi -- Martin, Scott E -- Youle, Richard J -- Intramural NIH HHS/ -- England -- Nature. 2013 Dec 12;504(7479):291-5. doi: 10.1038/nature12748. Epub 2013 Nov 24.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉1] Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA [2] Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland 20850, USA [3]. ; 1] Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA [2]. ; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA. ; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland 20850, USA. ; NIH Center for Regenerative Medicine, Bethesda, Maryland 20892, USA.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/24270810" target="_blank"〉PubMed〈/a〉
Keywords:
Adaptor Proteins, Signal Transducing/metabolism
;
Genome, Human/*genetics
;
HCT116 Cells
;
HEK293 Cells
;
HSP70 Heat-Shock Proteins/metabolism
;
HeLa Cells
;
Humans
;
Membrane Proteins/metabolism
;
Mitochondria/metabolism/pathology
;
*Mitochondrial Degradation
;
Mitochondrial Membranes/metabolism
;
Mitochondrial Proteins/metabolism
;
Multigene Family/genetics
;
Parkinson Disease/metabolism/pathology
;
Protein Kinases/metabolism
;
Protein Transport
;
*RNA Interference
;
RNA, Small Interfering/analysis/genetics
;
Reproducibility of Results
;
Ubiquitin-Protein Ligases/*metabolism
Print ISSN:
0028-0836
Electronic ISSN:
1476-4687
Topics:
Biology
,
Chemistry and Pharmacology
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink
